1295512

Alexander Babatunde Olawaiye, M.D — FEI 3040069150

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 19, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pittsburgh, PA (United States)

Additional Details

Clinical Investigator (CI)